Skip to main content

Table 4 Pharmacists’ perceived extent of involvement in general patient care and palliative care services

From: Pharmacists’ knowledge, attitude and involvement in palliative care in selected tertiary hospitals in southwestern Nigeria

My involvement in patient care as a pharmacist entails:

Not at all

n (%)

Rarely

n (%)

Occasionally n (%)

Frequently n (%)

1.Explain misconceptions about addictive medication (n = 110)

7 (6.4)

18 (16.4)

37 (33.6)

48 (43.6)

2. Visit patients’ homes to communicate directly with patients and their caregivers and to make necessary assessments (n = 110)

60 (54.5)

36 (32.7)

11 (10.0)

3 (2.7)

3. Monitor patients’ medication profile for safety and effectiveness (n = 109)

2 (1.8)

31 (28.4)

33 (30.3)

43 (39.4)

4. Provide patients with essential medications that ensure continuous symptom control (n = 110)

14 (12.7)

6 (5.5)

15 (13.6)

75 (68.2)

5. Attend clinical meetings to advise other members of healthcare team about medication therapy (n = 110)

12 (10.9)

22 (20.0)

45 (40.9)

31 (28.2)

6. Advise clinical team on dosage forms and adjustments, routes of administration, costs, and availability of various drug products (n = 110)

15 (13.6)

13 (11.8)

42 (38.2)

40 (36.4)

7. Give educational sessions (n = 110)

15 (13.6)

23 (20.9)

47 (42.7)

25 (22.7)

8. Advise members of the clinical team about the potential for toxicity and interactions with dietary supplements and alternative therapies (n = 110)

13 (11.8)

34 (30.9)

37 (33.6)

26 (23.6)

9. Ensure that all medication labeling is complete and understandable by patients and their caregivers (n = 110)

4 (3.6)

4 (3.6)

2 (1.8)

100 (90.9)

10. Communicate with patients about the importance of adhering to the prescribed drug regimen (n = 110)

0 (0.0)

4 (3.6)

6 (5.5)

100 (90.9)

11. Monitor all prescription and nonprescription medication use (n = 108)

3 (2.8)

7 (6.5)

38 (35.2)

60 (55.5)

12. Counsel patients about potential toxicity of alternative and complementary therapies (n = 109)

2 (1.8)

9 (8.3)

35 (32.1)

63 (57.8)

13. Extemporaneous preparation of non-conventional dosage forms for ease of administration to patients (n = 109)

4 (3.7)

5 (4.6)

28 (25.7)

72 (66.1)

14. Prepare flavouring medications to promote compliance (n = 103)

5 (4.9)

16 (15.5)

40 (38.8)

42 (40.8)

15. Address issues on cost of patients’ medications (n = 110)

6 (5.5)

12 (10.9)

43 (39.1)

49 (44.5)

16. Ensure that drug disposal is in compliance with federal and state drug control and environmental protection laws and regulations (n = 103)

3 (2.9)

16 (15.5)

26 (25.2)

58 (56.3)

  1. n Number